National Institutes of Health: all 11,571 studies

Page 90 of 116. Open to participants first (945), then studies with results posted, then the rest; newest registration first within each.

• Identification of Donors of CD36-Deficient Platelets Among Japanese Individuals on the NIH CampusCompletedNCT00015639
• A Clinical Trial to Prevent the Complications of Insulin Resistance (Including Type-2 Diabetes)CompletedNCT00015626Phase 2
• Farm Work & Preterm Low Birthweight Among Hispanic WomenCompletedNCT00015613
• Community-Based Environmental Health InterventionCompletedNCT00015600Not applicable
• Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study)CompletedNCT00015587
• Air Pollution and Implantable Cardioverter DefibrillatorsCompletedNCT00015574
• Pesticides--Health Fertility and Reproductive RiskCompletedNCT00015561
• CATIE-Alzheimer's Disease TrialCompletedNCT00015548Not applicable
• Hematotoxic Effects of Particulate ExposureCompletedNCT00015483
• Diagnostic Evaluation of Patients With Neuromuscular DiseaseCompletedNCT00015470
• Screening and Natural History: Primary Lateral Sclerosis and Related DisordersCompletedNCT00015444
• Immune System and Gut Abnormalities in Patients With Common Variable Immunodeficiency With and Without Gastrointestinal SymptomsCompletedNCT00015431
• Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14CompletedNCT00015340Phase 4
• Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11CompletedNCT00015301Phase 4
• Buprenorphine and Naloxone Combination Study - 10CompletedNCT00015288Phase 1
• Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9CompletedNCT00015275Phase 4
• Prepulse Inhibition of Startle in Cocaine Dependence - 7CompletedNCT00015249Phase 1
• Modeling Impaired Judgement in Cocaine Abusers - 6CompletedNCT00015236Phase 4
• Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Disorder - 5CompletedNCT00015223Phase 2
• Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1CompletedNCT00015171Phase 3
• Tiagabine, Sertraline, or Donepezil for the Treatment of Cocaine Dependence - 9CompletedNCT00015132Phase 2
• Resperine, Gabapentin, or Lamotrigine for the Treatment of Cocaine Dependence: 2 - 7CompletedNCT00015106Phase 2
• Naltrexone in Treatment of Cocaine Dependence - 5CompletedNCT00015080Phase 2
• Cocaine-Methylphendidate Interaction Study - 4CompletedNCT00015067Phase 1
• Methylphendidate Treatment of Cocaine Dependent Patients With Attention Deficit Hyperactivity Disorder - 3CompletedNCT00015054Phase 2
• Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2CompletedNCT00015041Phase 1
• Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1CompletedNCT00015028Phase 2
• Dichloroacetate Kinetics, Metabolism and ToxicologyCompletedNCT00015015
• Physiologic Studies of SpasticityCompletedNCT00014976
• Biomarkers of Benzene Exposure in Inner City ResidentsCompletedNCT00014963
• Benefits and Risks of Newborn Screening for Cystic FibrosisCompletedNCT00014950Not applicable
• Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination RegimenCompletedNCT00014937Not applicable
• Attention Deficit Disorder and Exposure to LeadCompletedNCT00014898
• Bone Lead Levels and College Achievement ScoresCompletedNCT00014885
• Reducing Pesticide Exposure in Minority FamiliesCompletedNCT00014807Not applicable
• Positron Emission Tomography and Magnetic Resonance Imaging to Evaluate Synovial Blood Flow in Rheumatoid Arthritis PatientsCompletedNCT00014794Phase 1
• Study of Metabolic Effects of Pregnancy in Women With Cystic FibrosisTerminatedNCT00014768
• Karenitecin in Treating Patients With Recurrent Malignant GliomaCompletedNCT00014521Phase 1
• Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00014170Phase 2
• A Study of Immune System Activity in Healthy AdultsCompletedNCT00014053
• Nitric Oxide Inhalation Therapy to Relieve Chest Pain in Patients With Coronary Artery DiseaseCompletedNCT00014040Phase 2
• Effect of Polyunsaturated Fatty Acids on Cardiovascular and Motor Responses Under StressCompletedNCT00014027Phase 1
• Zidovudine and Lamivudine Given Once Versus Twice DailyCompletedNCT00014014Phase 1
• CATIE- Schizophrenia TrialCompletedNCT00014001Phase 4
• Endothelial Progenitor Cells and Risk Factors for Coronary Artery DiseaseCompletedNCT00013975
• Vitamin D Metabolism and the Williams SyndromeCompletedNCT00013962
• Cardiovascular Vulnerability to Particulate ExposureCompletedNCT00013949
• A Novel Acuity Testing MethodCompletedNCT00013936
• Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer DiseaseCompletedNCT00013923Phase 2
• NNC 90-1170 Mechanism of Action: A Double-Blind, Randomized, Single-Center, Placebo-Controlled, Crossover Study to Examine Beta-Cell Responsiveness to Graded Glucose Infusion in Subjects With Type 2 DiabetesCompletedNCT00013910Phase 1
• HIV Maintenance Therapy With T-20 During HAART InterruptionCompletedNCT00013884Phase 2
• Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV DrugsCompletedNCT00013871Not applicable
• Environmental Contaminants and Infant DevelopmentCompletedNCT00013858
• Evaluation and Treatment of Patients With EpilepsyTerminatedNCT00013845
• Study of Tongue PressuresCompletedNCT00013832
• Exposure, Dose, Body Burden and Health Effects of LeadCompletedNCT00013819
• CHP677: I-Metaiodobenzylguanidine (I-MIBG) Therapy for Refractory Neuroblastoma: a Phase II StudyStatus unknownNCT00013806Phase 2
• Ultrasound and Motivational Enhancement for Prenatal Smoking CessationCompletedNCT00013793Not applicable
• Ozone Exposure and Dose Delivered to Human LungsCompletedNCT00013780
• Community Based Prevention/Control ProjectCompletedNCT00013767Not applicable
• Pesticide Exposure Pathways for Farmworker ChildrenCompletedNCT00013754
• The MI-HEART ProjectCompletedNCT00013741Not applicable
• Asthma & Exposure to Peaks in Particulate Air PollutionCompletedNCT00013728
• Ozone and Rhinovirus-Induced Disease in AsthmaticsCompletedNCT00013715
• Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected PatientsCompletedNCT00013702Phase 2
• Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative SyndromeCompletedNCT00013689Phase 1
• Immune Therapies and Anti-HIV Therapy Withdrawal in Controlling Viral LoadCompletedNCT00013663Phase 2
• Effects of an Anti-Inflammatory Drug in Alzheimer's DiseaseCompletedNCT00013650Phase 1
• Lead Exposure, Genetics, and Osteoporosis EpidemiologyCompletedNCT00013637
• Riluzole to Treat Parkinson's DiseaseCompletedNCT00013624Phase 2
• Treatment of Nonalcoholic Steatohepatitis With PioglitazoneCompletedNCT00013598Phase 2
• Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV PatientsCompletedNCT00013585Phase 2
• Natural History Study of Smith-Magenis SyndromeCompletedNCT00013559
• Hormone Replacement Therapy to Treat Turner SyndromeCompletedNCT00013546Phase 2
• Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic MalignanciesCompletedNCT00013533Early Phase 1
• Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV InfectionCompletedNCT00013520Phase 3
• Treatment of Youth With ADHD and AnxietyCompletedNCT00012584Not applicable
• Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)CompletedNCT00012558Not applicable
• Collection and Storage of Umbilical Cord Stem Cells for Treatment of Sickle Cell DiseaseCompletedNCT00012545
• Ritonavir and Indinavir in Children Failing Other Anti-HIV TreatmentCompletedNCT00012519Phase 1/2
• The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid ArthritisStatus unknownNCT00012506Phase 3
• Cardiac Vulnerability in Potentially Susceptible PatientsCompletedNCT00012493
• Effect of Environmental Exposures on the Egg Fertilizing Ability of Human SpermCompletedNCT00012480
• E-Selectin Nasal Spray to Prevent Stroke RecurrenceTerminatedNCT00012454Phase 2
• Comparison of Daily Nocturnal Hemodialysis With Daily HemodialysisStatus unknownNCT00012441Not applicable
• Prenatal PCB ExposureCompletedNCT00012428
• Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid CancerCompletedNCT00012376Phase 1
• 7-hydroxystaurosporine and Cisplatin in Treating Patients With Advanced Malignant Solid TumorsTerminatedNCT00012194Phase 1
• Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or LymphomasCompletedNCT00012181Phase 1
• Humanized LL2IGG to Treat Systemic Lupus ErythematosusCompletedNCT00011908Phase 1
• Genetic Analysis of Familial Brain AneurysmsCompletedNCT00011856
• Molecular Analysis of Microphthalmia/AnophthalmiaCompletedNCT00011843
• Stem Cell Mobilization Potential in Patients With Aplastic Anemia in RemissionCompletedNCT00011830Phase 1
• Evaluation and Treatment of Patients With Inherited Eye DiseasesCompletedNCT00011817
• Topiramate in the Treatment of SciaticaCompletedNCT00011804Phase 2
• Catecholamine Reserve and Exercise Tolerance in Healthy Volunteers and Patients With Congenital Adrenal HyperplasiaCompletedNCT00011791
• PS-341 and Radiation to Treat Advanced Cancer of the Head and NeckCompletedNCT00011778Phase 1
• Effect of Fluoxetine (Prozac) on Domestic ViolenceCompletedNCT00011765Phase 2
• Serotonin in AlcoholismCompletedNCT00011752
• Lead Mobilization & Bone Turnover in Pregnancy/LactationCompletedNCT00011726

← National Institutes of Health overview and focus areas